Exchange: NASDAQ·Updated 07:58 PM EDT
DNTH logo

DNTH Dianthus Therapeutics Inc

$108.10
$0.25
(0.23%)
Today
Closed $108.10
$0.01
(0.01%)
After Hours
EarningsNov 5
Mkt Cap$6.03B
Vol638,559.00

About DNTH

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
42

Bearish Sentiment

How do you feel about DNTH?

Advertisement|Remove ads.